The Risks of Overbroad Motions to Seal
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Before Prost, Mayer, and Taranto. Appeal from the United States District Court for the Northern District of California.
Summary: Motions to seal must be narrowly tailored and well supported to overcome the presumption of public access to court filings.
In the District Court, Uniloc moved to seal a large amount of allegedly confidential information referenced in several Apple motions to dismiss. The material sought to be sealed included citations to case law, quotations from published opinions, and twenty three exhibits that included matters of public record. The District Court denied the motions to seal, stating that Uniloc had not provided compelling reasons to overcome the public’s right to the information. Uniloc’s motions were not “narrowly tailored,” and requested an “astonishing” amount of material be sealed.
The Federal Circuit, reviewing the disputed order under the collateral order doctrine, affirmed in part and vacated in part. The Federal Circuit divided the information Uniloc sought to seal into two categories: 1) Uniloc’s own purportedly confidential information; and 2) the purportedly confidential information of Uniloc’s third-party licensees. With respect to Uniloc’s allegedly confidential information, the District Court did not abuse its discretion because Uniloc “fell woefully short” of the local rule requirement to narrowly tailor its request and Uniloc provided only “perfunctory assertions” that the documents required sealing. With respect to third-party licensees, the Federal Circuit vacated and remanded because the District Court did not properly assess whether the public’s right of access outweighed the confidentiality interest of the third parties.
Editor: Paul Stewart
Written by: Victoria E. Ellis & Mark Kachner
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…